HMQ Partners is a Consultancy company specialized in pricing and market access strategies for healthcare companies.
HMQ Partners offers expert support to :
Medical device, vaccines, pharmaceuticals, generics and biotechnologies companies
Start-ups, small companies, big pharma
Public institutions: patient associations, hospitals…
Today, building a successful market access strategy for a healthcare product depends not only on the product’s effectiveness and safety. An expert understanding of the fast evolving regulatory framework and the economical criteria influencing authorities decision-making process is critical.
Beyond collecting clinical data to prove a product’s efficacy, manufacturers have to demonstrate how their products contribute to lowering overall treatment costs. Quantifying the cost benefit to the public purse is critical for the price setting process.
To better respond to the market changes caused by increasingly stringent regulations, healthcare manufacturers are putting Market Access at the core of their strategy, starting from the clinical development phase.
HMQ Partners supports you on all aspects of Pricing and Market Access throughout your product’s life cycle: from the clinical development phase to reimbursement and post-marketing follow-up.
you have just developed an innovative healthcare product and you would like to market it.
a patient association
you wish to accelerate the reimbursement of a healthcare product in France.
a small, medium or large sized company
you need strategic or operational consultancy support.